Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:15628769rdf:typepubmed:Citationlld:pubmed
pubmed-article:15628769lifeskim:mentionsumls-concept:C1123023lld:lifeskim
pubmed-article:15628769lifeskim:mentionsumls-concept:C0024109lld:lifeskim
pubmed-article:15628769lifeskim:mentionsumls-concept:C0087111lld:lifeskim
pubmed-article:15628769lifeskim:mentionsumls-concept:C0278502lld:lifeskim
pubmed-article:15628769lifeskim:mentionsumls-concept:C0027627lld:lifeskim
pubmed-article:15628769lifeskim:mentionsumls-concept:C0144576lld:lifeskim
pubmed-article:15628769lifeskim:mentionsumls-concept:C1533148lld:lifeskim
pubmed-article:15628769lifeskim:mentionsumls-concept:C0332293lld:lifeskim
pubmed-article:15628769pubmed:issue13lld:pubmed
pubmed-article:15628769pubmed:dateCreated2005-1-4lld:pubmed
pubmed-article:15628769pubmed:abstractTextA case of recurrent gastric cancer with metastases to the skin and lung was treated successfully with low-dose paclitaxel after oral TS-1 administration. The patient was a 73-year-old man who underwent total gastrectomy for gastric cancer on April 3, 2000. Two years and four months after the operation, an increasing CA19-9 concentration and metastases to the skin and both lungs were observed. Oral TS-1 was given, but had to be stopped because of diarrhea. The metastatic lesions of the skin were resected, and low-dose paclitaxel (100 mg) was given once a week for 6 weeks. Five months later, the metastatic lesions of the right and left lung had decreased in size by 62% and 100%, respectively. CA19-9 fell to below the cut-off value 2 months after starting therapy. A decrease in the hemoglobin level of grade 1 was observed. Low-dose paclitaxel for recurrent gastric cancer after TS-1 therapy causes few side effects and may well be effective.lld:pubmed
pubmed-article:15628769pubmed:languagejpnlld:pubmed
pubmed-article:15628769pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15628769pubmed:citationSubsetIMlld:pubmed
pubmed-article:15628769pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15628769pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15628769pubmed:statusMEDLINElld:pubmed
pubmed-article:15628769pubmed:monthDeclld:pubmed
pubmed-article:15628769pubmed:issn0385-0684lld:pubmed
pubmed-article:15628769pubmed:authorpubmed-author:OsugiHarushiHlld:pubmed
pubmed-article:15628769pubmed:authorpubmed-author:IwasakiHirosh...lld:pubmed
pubmed-article:15628769pubmed:authorpubmed-author:KanekoMasahir...lld:pubmed
pubmed-article:15628769pubmed:authorpubmed-author:TakemuraMasas...lld:pubmed
pubmed-article:15628769pubmed:authorpubmed-author:TanakaYoshino...lld:pubmed
pubmed-article:15628769pubmed:authorpubmed-author:NishizawaSato...lld:pubmed
pubmed-article:15628769pubmed:authorpubmed-author:LeeShigeruSlld:pubmed
pubmed-article:15628769pubmed:authorpubmed-author:FujiwaraYushi...lld:pubmed
pubmed-article:15628769pubmed:issnTypePrintlld:pubmed
pubmed-article:15628769pubmed:volume31lld:pubmed
pubmed-article:15628769pubmed:ownerNLMlld:pubmed
pubmed-article:15628769pubmed:authorsCompleteYlld:pubmed
pubmed-article:15628769pubmed:pagination2187-9lld:pubmed
pubmed-article:15628769pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:15628769pubmed:meshHeadingpubmed-meshheading:15628769...lld:pubmed
pubmed-article:15628769pubmed:meshHeadingpubmed-meshheading:15628769...lld:pubmed
pubmed-article:15628769pubmed:meshHeadingpubmed-meshheading:15628769...lld:pubmed
pubmed-article:15628769pubmed:meshHeadingpubmed-meshheading:15628769...lld:pubmed
pubmed-article:15628769pubmed:meshHeadingpubmed-meshheading:15628769...lld:pubmed
pubmed-article:15628769pubmed:meshHeadingpubmed-meshheading:15628769...lld:pubmed
pubmed-article:15628769pubmed:meshHeadingpubmed-meshheading:15628769...lld:pubmed
pubmed-article:15628769pubmed:meshHeadingpubmed-meshheading:15628769...lld:pubmed
pubmed-article:15628769pubmed:meshHeadingpubmed-meshheading:15628769...lld:pubmed
pubmed-article:15628769pubmed:meshHeadingpubmed-meshheading:15628769...lld:pubmed
pubmed-article:15628769pubmed:meshHeadingpubmed-meshheading:15628769...lld:pubmed
pubmed-article:15628769pubmed:meshHeadingpubmed-meshheading:15628769...lld:pubmed
pubmed-article:15628769pubmed:meshHeadingpubmed-meshheading:15628769...lld:pubmed
pubmed-article:15628769pubmed:year2004lld:pubmed
pubmed-article:15628769pubmed:articleTitle[A case of recurrent gastric cancer with skin and lung metastasis treated by low-dose paclitaxel therapy].lld:pubmed
pubmed-article:15628769pubmed:affiliationDept of Gastroenterological Surgery, Osaka City University Graduate School of Medicine.lld:pubmed
pubmed-article:15628769pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:15628769pubmed:publicationTypeEnglish Abstractlld:pubmed
pubmed-article:15628769pubmed:publicationTypeCase Reportslld:pubmed